These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19231456)

  • 1. Is pneumonectomy justified in patients with locally advanced NSCLC and persistent N2 disease after induction chemotherapy?
    Klomp HM; Kappers I
    Ann Thorac Surg; 2009 Mar; 87(3):990-1. PubMed ID: 19231456
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients with resectable stage IIIA (N2) NSCLC.
    Azzoli CG
    J Surg Oncol; 2006 Dec; 94(7):551-2. PubMed ID: 17111389
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
    d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary.
    Goldberg M
    Ann Thorac Surg; 2006 Jan; 81(1):304. PubMed ID: 16368386
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy for resected non-small cell lung cancer.
    Wakelee H; Chhatwani L
    Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonectomy after induction radiochemotherapy: is it time for a meta-analysis?
    Cusumano G; Cesario A; Margaritora S
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):806-7; author reply 807. PubMed ID: 20176239
    [No Abstract]   [Full Text] [Related]  

  • 8. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
    Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery after induction chemoradiotherapy for non small cell lung cancer: when and why.
    Koletsis EN; Prokakis C; Apostolakis E; Chatzimichalis A; Dougenis D
    J BUON; 2007; 12(4):453-61. PubMed ID: 18067202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiation therapy for non-small cell lung cancer.
    Decker RH; Wilson LD
    Semin Thorac Cardiovasc Surg; 2008; 20(3):184-7. PubMed ID: 19038726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical lung resection after neoadjuvant chemoradiotherapy.
    Burrows WM
    Semin Thorac Cardiovasc Surg; 2007; 19(4):360-5. PubMed ID: 18395639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
    Berghmans T
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stage III NSCLC. The surgeon's role in exploration and treatment].
    van Schil P; de Waele M; Hendriks J; Lauwers P
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S88-94. PubMed ID: 18971831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy.
    Mitsos S; Petko M; Patrini D; Hayward M; Scarci M; Lawrence D; Panagiotopoulos N
    Indian J Cancer; 2017; 54(1):73-81. PubMed ID: 29199668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential indications for induction therapy of non-small-cell lung tumors].
    Drings P; Manegold C
    Chirurg; 2000 Dec; 71(12):1466-73. PubMed ID: 11195065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative chemotherapy for early-stage disease: an extra chance for the patient?].
    Milleron B; Lavolé A
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S3-7. PubMed ID: 15211225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.